Pro-Dex (NASDAQ:PDEX) Share Price Passes Above 200 Day Moving Average - Should You Sell?

Key Points

• Pro-Dex shares recently crossed above their 200-day moving average of $40.85, trading as high as $51.56 and last at $49.84 on volume of 23,590 shares—a technical breakout signal for investors.
• The company reported a quarterly earnings beat, with EPS of $0.66 versus $0.59 expected and revenue of $18.66 million versus $17.30 million, while posting a net margin of 15.73% and ROE of 22.53%.
• Pro-Dex has a market cap of $159.8 million and a P/E of 14.66, together with strong liquidity (current ratio 4.03, quick ratio 2.25) and low leverage (debt-to-equity 0.19); institutional investors own about 15.28% of the stock with some recent buying activity.

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $40.85 and traded as high as $51.56. Pro-Dex shares last traded at $49.84, with a volume of 23,590 shares changing hands.

Pro-Dex Trading Down 3.2%

The business has a 50-day moving average price of $48.41 and a two-hundred day moving average price of $40.85. The stock has a market capitalization of $159.79 million, a P/E ratio of 14.66 and a beta of -0.11. The company has a current ratio of 4.03, a quick ratio of 2.25 and a debt-to-equity ratio of 0.19.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last released its earnings results on Thursday, January 29th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.59 by $0.07. Pro-Dex had a return on equity of 22.53% and a net margin of 15.73%.The firm had revenue of $18.66 million during the quarter, compared to the consensus estimate of $17.30 million.

Hedge Funds Weigh In On Pro-Dex

Institutional investors have recently modified their holdings of the business. Los Angeles Capital Management LLC acquired a new position in shares of Pro-Dex during the 4th quarter worth $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Pro-Dex during the 2nd quarter worth $50,000. AlphaQuest LLC acquired a new position in shares of Pro-Dex during the 3rd quarter worth $71,000. Bank of America Corp DE raised its holdings in shares of Pro-Dex by 173.3% during the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier's stock worth $74,000 after buying an additional 1,073 shares in the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of Pro-Dex by 65.4% during the 4th quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier's stock worth $89,000 after buying an additional 915 shares in the last quarter. Institutional investors and hedge funds own 15.28% of the company's stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.